4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online

13744
Reinforcement Learning From Verifiable Rewards In Cns Drug Optimization
Poster Presenter
Authors
Affiliations
Part of Topic
Drug Development -> Nonhuman -> Lead optimization studies
REINFORCEMENT LEARNING FROM VERIFIABLE REWARDS IN CNS DRUG OPTIMIZATION
DAVID SCOTT LEWIS, ENRIQUE ZUECO, HALEY YI
AIXC BIO, ZARAGOZA, SPAIN | REPORTS@AIXCBIO.COM
ALZHEIMER'S ASSOCIATION
AAIC '26
KEY TAKEAWAY
Verifiable Physics-Based Rewards Enable True Autonomous Self-Improvement for Multi-Parameter CNS Drug Optimization.
INTRODUCTION
Designing Brain-Penetrant Therapeutics requires balancing multi-parameter constraints:
- Solubility vs. Blood-Brain Barrier (BBB) permeability
- Lipophilicity
Why current methods (like pure LLMs) fail:
Pure LLMs fail without verifiable biological feedback rewards.
METHODS
Primary Objectives:
- Autonomous CNS optimization goals
- Multi-target BBB crossing and optimal lead generation
Reward Calculation Detail:
- Tau dock score -> Deterministic Physics-Based Reward Function -> Verifiable Scalar Reward
- BBB value -> Deterministic Physics-Based Reward Function -> Verifiable Scalar Reward
This is superior to scalar reward models based on human preference.
CLOSED-LOOP SYSTEM FOR TAU INHIBITORS
SMILES Strings -> AI AGENT -> TEST-TIME RECURSIVE THINKING -> VERIFIABLE REWARD EVALUATION (SIMULATION)
VERIFIABLE REWARD EVALUATION (SIMULATION) -> MOLECULAR DOCKING (Tau Aggregation) + In Silico BLOOD-BRAIN BARRIER (BBB) PERMEABILITY SIMULATION -> HARD SCALAR REWARDS -> FEEDBACK -> AI AGENT (Loop repeats)
RESULTS
SUCCESS RATE IMPROVEMENT
(Bar chart showing +42% improvement)
BINDING AFFINITY vs. BBB PERMEABILITY
(Scatter plot showing Binding Affinity vs. BBB Permeability)
Rapid Autonomous Self-Improvement
(Arrow pointing right indicating Time, with molecular structures shown)
CONCLUSIONS
AUTONOMOUS SELF-DRIVING DRUG DISCOVERY PIPELINE
AUTOMATED SYNTHESIS -> TESTING -> AI-LED DESIGN (Loop)
- Significance: Establishes a verifiable path towards faster, more effective Alzheimer's drug discovery.
- Validates physics-grounded AI learning as scalable for complex multi-objective optimization.
- Future Directions: Generalization to other target classes; Regulatory pathways for autonomous discovery frameworks.
Comments
Email is required but is not shown publicly.
Loading comments...
